This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Inventor Spotlight: Steven Richards
Introduction: Steven Richards, located in Stanford, California, is an innovative inventor known for his contributions to the field of biochemistry. With a focus on inhibiting phospholipid synthesis, his groundbreaking work has the potential to transform the landscape of cancer treatment and metabolic disorders.
Latest Patents: Steven holds a patent for "Inhibitors of phospholipid synthesis and methods of use." This patent specifically addresses inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT), outlining their applications in treating cancer as well as conditions related to metabolic syndrome and hyperlipidemia.
Career Highlights: Steven Richards is currently affiliated with the Leland Stanford Junior University, where he collaborates and conducts research aimed at advancing medical treatments. His contributions to the scientific community are underscored by his patent, which showcases his expertise and innovative thinking in biochemistry.
Collaborations: Throughout his career, Steven has worked closely with notable colleagues, including Arvin Gouw and Dean W. Felsher. Their collaborative efforts aim to explore and develop effective therapies that address critical health issues.
Conclusion: As an inventor and researcher, Steven Richards exemplifies the spirit of innovation in the academic and medical fields. His contributions through his patent not only advance scientific knowledge but also hold promise for improving treatment options for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile